Epitomee Medical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Dan Hashimshony
Chief executive officer
US$359.0k
Total compensation
| CEO salary percentage | 87.5% |
| CEO tenure | 7yrs |
| CEO ownership | n/a |
| Management average tenure | 5yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
Statutory Profit Doesn't Reflect How Good Epitomee Medical's (TLV:EPIT) Earnings Are
Nov 20
Here's Why We're Not Too Worried About Epitomee Medical's (TLV:EPIT) Cash Burn Situation
Oct 15We Like These Underlying Return On Capital Trends At Epitomee Medical (TLV:EPIT)
Aug 18We Think Epitomee Medical (TLV:EPIT) Can Afford To Drive Business Growth
Jun 26CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$3m |
| Jun 30 2024 | n/a | n/a | -US$6m |
| Mar 31 2024 | n/a | n/a | -US$6m |
| Dec 31 2023 | US$359k | US$314k | -US$6m |
Compensation vs Market: Dan's total compensation ($USD359.00K) is about average for companies of similar size in the IL market ($USD418.81K).
Compensation vs Earnings: Insufficient data to compare Dan's compensation with company performance.
CEO
Dan Hashimshony (59 yo)
7yrs
Tenure
US$359,000
Compensation
Dr. Radan Hashimshony, also known as Dan is the Chief Executive Officer at Epitomee Medical Ltd since 2018 and serves as its General Secretary. He founded Dune Medical Devices Corporation in 2002 and serve...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman of the Board | 19.6yrs | US$46.00k | 27.88% ₪ 72.1m | |
| CEO & General Secretary | 7yrs | US$359.00k | no data | |
| Vice President of Finance | 5yrs | US$414.00k | no data | |
| Chief Operating Officer | 5yrs | US$312.00k | no data | |
| Vice President of Clinical Affairs | 5yrs | US$267.00k | no data | |
| VP of Sales and Marketing | 1yr | no data | no data | |
| Chief Medical & Regulatory Officer | no data | no data | no data | |
| CEO of R&D | 7yrs | no data | no data |
5.0yrs
Average Tenure
60yo
Average Age
Experienced Management: EPIT's management team is seasoned and experienced (5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman of the Board | 19.6yrs | US$46.00k | 27.88% ₪ 72.1m | |
| Director | 5.8yrs | no data | no data | |
| Independent External Director | 1.4yrs | no data | no data | |
| Director | 7yrs | no data | no data | |
| Independent External Director | 2.8yrs | no data | no data | |
| Director | 4.1yrs | no data | 0.83% ₪ 2.1m | |
| Independent Director | 1.4yrs | no data | no data |
4.1yrs
Average Tenure
58yo
Average Age
Experienced Board: EPIT's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/25 00:32 |
| End of Day Share Price | 2025/01/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Epitomee Medical Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|